All News #Library
Biotech
Preclinical Dosing Insights for Liver Gene Therapy at ASGCT Meet
14 May 2025 //
GLOBENEWSWIRE
Genespire to present preclinical insights on liver-directed ISLV
07 May 2025 //
GLOBENEWSWIRE
Genespire raises 46.6M in a Series B to advance in-vivo therapy
24 Sep 2024 //
GLOBENEWSWIRE
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
12 Sep 2024 //
GLOBENEWSWIRE
Genespire Positive Preclinical Data At ASGCT Annual Meeting
09 May 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support